Manage cookies
Cookie Settings
Cookies necessary for the correct operation of the site are always enabled.
Other cookies are configurable.
Other cookies are configurable.
AGENDA 2026
AGENDA 2026
AGENDA 2026
AGENDA 2026
AGENDA 2026
AGENDA 2026
Pre-Forum Day, January 26
19:00
19:00
Welcome Reception and Networking Opportunities
Day 1, January 27
08:00 – 09:00
08:00 – 09:00
Participant Registration.
Morning Coffee & Networking
Morning Coffee & Networking
09:00 – 09:10
09:00 – 09:10
Forum Opening.
Welcome Address by Organizers
Welcome Address by Organizers
09:10 – 10:30
09:10 – 10:30
Plenary Discussion. The Eurasian Pharma Market: The Industry's View on Challenges and Prospects
- EAEU Pharma Market: Growth, Barriers, Prospects
- Production Localization: Incentives, Challenges, Success Stories
- The Impact of Regulatory Requirements on Business Strategies
- Liberalization of Public Procurement: New Opportunities for Business
-
Moderator:
VYACHESLAV LOKSHINPresident, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan -
LARISA MATVEEVA
Executive Director
Association of International Pharmaceutical Manufacturers -
ALEXANDER BYKOV
Director of Healthcare Economics, R-Pharm
10:30 – 11:00
10:30 – 11:00
Coffee Break & Networking
11:00 – 12:20
11:00 – 12:20
Plenary Session. State and Business: Creating Conditions for Industry Development
- Legislative Changes: New Registration Rules, GMP Inspections, Clinical Trials
- Harmonization of Requirements in the EAEU: Progress and Next Steps
- Support for Localization and Innovation: Government Incentive Measures
- Plans for Improving the Investment Climate in the Pharmaceutical Industry
- Medicine Supply in CIS Countries: Discussion of the Model Law
-
RASHAD MAHMUDOV
Deputy Chairman of the Health Committee, Milli Majlis of the Republic of Azerbaijan -
VADIM KUKAVA
Executive Director, Association of Pharmaceutical Companies "Pharmaceutical Innovations" ("InPharma")
12:20 – 13:00
12:20 – 13:00
Coffee Break & Networking
13:00 – 14:20
13:00 – 14:20
Panel Session. The Future of Medicine Registration in the Eurasian Region
- Unification of Registration Rules in the EAEU: Progress and Remaining Barriers
- Uzbekistan's Experience in Aligning with EAEU Norms
- Simplified Procedures for Innovative and Orphan Drugs
- Pharmacopoeial Standards: Current Changes and Impact on Quality
- Reducing Registration Timelines Through Unified Standards
- The Impact of Regulatory Changes on Supply Chains
-
MIRBEK NYSHANBAEV
Head of the Department of Drug Registration, Department of Drugs and Medical Devices, Ministry of Health of the Republic of Kyrgyzstan -
National Center for the Expertise of Medicines and Medical Devices
14:20 – 15:20
14:20 – 15:20
Lunch Break
15:20 – 16:40
15:20 – 16:40
Panel Session. Pricing and Economic Efficiency in the Pharmaceutical Industry
- Comparison of Pricing Models in the EAEU and CIS
- Financing High-Cost Therapy: Mechanisms and Challenges
- Reference Pricing: Country Selection and Complexities
- Opportunities for a Unified Pricing Mechanism in the EAEU
- Balancing the Interests of Patients, the State, and Business
-
Moderator:
MARINA DURMANOVAPresident, Association for the Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan -
LARISSA YEMELYANOVA
Partner, AEQUITAS Law Firm -
ZAFAR VAKHIDOV
Partner, Vakhidov & Partners
16:40 – 17:10
16:40 – 17:10
Coffee Break & Networking
17:10 – 18:30
17:10 – 18:30
Panel Session. Modern Models of Intellectual Property Protection and Management in the Pharmaceutical Industry
- Patent Protection Strategies and Early Generic Entry
- Compulsory Licensing and Legal Disputes in the EAEU
- Specifics of Patenting Innovative Drugs
- Parallel Import: Risks and Opportunities
- Combating Counterfeits and Copies
-
Moderator:
VADIM KUKAVAExecutive Director, Association of Pharmaceutical Companies "Pharmaceutical Innovations" ("InPharma") -
ALEXANDER PANOV
Senior Partner, VERBA LEGAL -
Agency for Protection and Development of Competition of the Republic of Kazakhstan
18:30
18:30
End of Day 1. Evening Reception and Informal Networking
Day 2, January 28
08:30 – 09:00
08:30 – 09:00
Morning Coffee & Networking
09:00 – 10:20
09:00 – 10:20
Expert Analytical Panel. Analysis of the EAEU Pharmaceutical Market: Key Trends, Challenges, and Growth Points
- Sales Volumes and Segment Share (Generics, Innovators, Biologics)
- Market Growth Forecasts until 2027
- Comparison with Global Trends
- Impact of Inflation and Exchange Rate Fluctuations
- Transformation of Consumer Preferences
- Pharma Business Prospects for the Next 10 Years
10:20 – 10:50
10:20 – 10:50
Coffee Break & Networking
10:50 – 12:10
10:50 – 12:10
Panel Session. National Pharmaceutical R&D Projects: Integrating Science, Production, and International Partnership
- Search for New Molecules and Localization of Biopharmaceutical Production
- Government Support: Funding, Certification, Procurement
- Successful International Partnerships
- Talent Retention and Development of Scientific Infrastructure
- National Drug Security
- Accelerated Scaling of Laboratory Technologies
12:10 – 12:40
12:10 – 12:40
Coffee Break & Networking
12:40 - 14:00
12:40 - 14:00
Panel Session. Commercialization of Pharmaceutical Products: Marketing and Digital Technologies
- Online-Offline Integration in Marketing
- Big Data and AI for Personalizing Communications
- Digital Promotion Channels (E-commerce, Social Media, Mobile Apps)
- Advertising Restrictions and Handling Personal Data
- Sales Automation via CRM and Medical Representatives
- Personalizing Interaction with Doctors and Pharmacies
-
LARISSA YEMELYANOVA
Partner, AEQUITAS Law Firm
14:00 - 15:00
14:00 - 15:00
Lunch Break
15:00 - 16:20
15:00 - 16:20
Panel Session. From Plant to Patient: Optimizing Pharmaceutical Product Supply in the New Reality
- Transport Corridors and Logistics Solutions
- Cold Chains and Customs Clearance
- Problems and Solutions in Implementing Track & Trace
- Digital Order Management Platforms
- Interaction Between Manufacturers, Distributors, and Pharmacies
- Combating Counterfeits Through Supply Chain Transparency
-
ALEXANDRA TIKHONOVA
Head of Projects, Department of Socially Significant Goods, Center for the Development of Advanced Technologies (CDAT) -
SK-Pharmacy
16:20 - 16:50
16:20 - 16:50
Coffee Break & Networking
16:50 – 18:00
16:50 – 18:00
Parallel sessions
Hall 1
How to Successfully Conduct Clinical Trials in EAEU Countries
- Legislative Changes and National Requirements (borders with medicines)
- Interaction with Medical Centers and Risk Management
- Using AI in Data Analysis
- GCP Inspections and Good Clinical Practice
- Logistics of Clinical Trials
- Labeling and Information Transparency
Speaker from Statandocs
Hall 2
The Dietary Supplements Market: New Consumer Trends and Growth Opportunities
- Consumption Trends and Classification
- Registration of Efficacy and Safety
- Combating Falsification and the Uncontrolled Market
- Growing Demand for Immunomodulators and Vitamins
- Online Promotion Without Violations
Moderator:
ALEXANDER ZHESTKOV
Executive Director, Union of Dietary Supplement Manufacturers
ALEXANDER ZHESTKOV
Executive Director, Union of Dietary Supplement Manufacturers
ALEXEY PETRENKO
Director of Global Projects, EAS Strategies
Director of Global Projects, EAS Strategies
18:00
18:00
Discussion and Signing of the Resolution. Summarizing and Closing of the Forum. Cocktail Reception
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
For any questions regarding participation, partnership, or registration, please reach out to our team: